INTRODUCTION
• The latest EAACI/GA2LEN/EDF/WAO* guidelines define chronic spontaneous (also known as idiopathic) urticaria (CSU/CIU) as the occurrence of wheals (hives) with or without angioedema for 6 weeks or longer due to known or unknown causes 1 • Although CSU/CIU is not life threatening, when not adequately controlled with therapies it has an impact on patients' life. However, quantification of this burden in terms of different domains of health-related quality of life (HRQoL) is scarce [2] [3] [4] • CSU/CIU has an impact on healthcare payers and also on society in terms of indirect costs (i.e., productivity losses arising from reduced performance at work or absence from work 5 ) • There is limited real world research quantifying the humanistic and economic impact of CSU/CIU on patients symptomatic despite treatment
OBJECTIVE
• The ASSURE-CSU study (ASsessment of the Economic and Humanistic Burden of Chronic Spontaneous/Idiopathic URticaria PatiEnts) was an observational, non-interventional, multinational, and multicenter study conducted in Canada, France, Germany, Italy, United Kingdom (UK), Spain and the Netherlands to identify and quantify the humanistic and economic burden of illness in CSU/CIU patients
• Here we present the results of the Canadian cohort analysis on economic burden in terms of work productivity and indirect costs
METHODS

Study Design
• Study design was based on a combination of retrospective patient medical record abstraction, a cross-sectional patient survey, and a 7-day patient diary
• Data collected included: patient demographics, co-morbidities, medical resources, treatment patterns, disease severity, HRQoL and productivity
Patient Population
• Clinician-confirmed, guideline-defined and diagnosed adult (≥18 years) CSU/CIU patients with at least one treatment course of an H 1 -antihistamine and with symptoms for more than 12 months were eligible to be part of the study
Outcomes
• CSU/CIU-related work days missed and productivity losses were measured using the Work Productivity and Activity Impairment-Specific Health Problem (WPAI-SHP) 
Data Analysis
• Urticaria severity was assessed prospectively over the 7 days following enrolment using the Urticaria Activity Score (UAS), a patient daily diary covering level of itch and number of hives. A weekly score (UAS7) is calculated ranging from 0 (no symptoms and signs) to 42 (the highest severity)
• Based on UAS7 scores, five disease severity levels can be described ( 
RESULTS
• In Canada, 9 sites (7 were specialist centers, 1 was specialist center and a hospital, and 1 was 'other') participated in the study and medical records were abstracted for 99 patients presenting with CSU/CIU as defined by the eligibility criteria
• Of the 99 patients included in the analysis, 88 (89%) completed the patient survey and 86 (87%) completed the patient diary. Two patients completed the patient diary but were not assigned a health state due to 3 or more missing daily urticaria activity scores. At baseline, one patient reported being itch free or hive free (UAS7=0), and was excluded from the analysis
• The mean age of patients at enrolment was 50.8 years, mean age of symptom onset was 42.9 years and age at the time of diagnosis was 45.8 years ( 
Health states based on UAS7
Note: One patient submitted an incomplete diary and therefore was not assigned a severity state SD, standard deviation; only positive values are presented for SD; Work productivity loss due to CSU/CIU (or overall work impairment) incorporates both absenteeism and presenteeism using the following validated Work Productivity and Activity Impairment algorithm: work productivity loss = absenteeism + (1-absenteeism)*presenteeism
DISCUSSION
• ASSURE-CSU is the first international study assessing the burden of CSU/CIU on symptomatic patients and the impact on healthcare and society • The Canadian cohort included patients symptomatic despite different therapies with an average duration of disease between diagnosis and recruitment of 5.2 years • As disease severity and impact on work and activity were assessed over the same period, the results suggest that symptoms have a negative impact on patient's capacity to perform overall activities and work 
